Filter posts

BIO-Europe Spring Opening Remarks

BIO’s own David Thomas, Director of Industry Research, delivered opening remarks at the BIO-Europe Spring …

Indices, IPOs, Approvals - YTD Update Aug 14th, 2012

We are now more than eight months into the year and biotech indices have maintained their outperformance, squeezed …

Indices, IPOs, and New Drug Approvals – Update July 6th 2012

1. Stock Performance. The Nasdaq Biotech Index (NBI) continued on its path of outperforming the …

Indices, IPOs, and New Drug Approvals - Update April 3rd 2012

1. Stock Performance. The Nasdaq Biotech Index (NBI) continued to outperform in March, maintaining its …

BIO Europe Spring 2012 - Opening Remarks

For Monday’s Opening Remarks at BIO Europe Spring 2012, I covered the following topics: Public …

Does Biotech History Repeat?

According to Mark Twain, “History does not repeat itself, but it does rhyme”. Little did he …

Biotech IPO Update for May 18th, 2011

There are now eight biotech IPOs for 2011, bringing the total for the recent US …

IPO Update - April 5th, 2011

The six biotech IPOs of 2011 have followed 2010’s IPO trends; all took significant haircuts getting …

BIO Europe Spring - State of the Biotech Industry

BIO Industry Analysis provided opening remarks at BIO Europe Spring in Milan, Italy, this morning.  …

Anitbody Deals Peaked in 2007

Antibody and antibody-like scaffold molecules have been on the pharma licensing radar for some time. …